Exposure of normal human melanocytes to a tumor promoting phorbol ester reverses growth suppression by transforming growth factor beta

Journal of Cellular Physiology

Volumn 214, Issue 2, 2008, Pages 363-370

  Stavroulaki, Melanthia ^a   Kardassis, Dimitris ^a   Chatzaki, Ekaterini ^b   Sakellaris, George ^c   Lindschau, Carsten ^d   Haller, Hermann ^d   Tosca, Androniki ^a   Krasagakis, Konstantin ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^c UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 4ALPHA PHORBOL DIDECANOATE; ANTISENSE OLIGODEOXYNUCLEOTIDE; CARCINOGEN; DIACYLGLYCEROL DERIVATIVE; GLYCEROL 2 ACETATE 1 OLEATE; PROTEIN KINASE C ALPHA; PROTEIN KINASE C INHIBITOR; SMAD PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DNA SYNTHESIS; DOWN REGULATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME SYNTHESIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MELANOCYTE; PRIORITY JOURNAL;

CARCINOGENS; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CULTURE MEDIA, SERUM-FREE; ENZYME INHIBITORS; GENES, REPORTER; HUMANS; INDOLES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KINETICS; LUCIFERASES; MALE; MELANOCYTES; MITOCHONDRIAL PROTEINS; OLIGONUCLEOTIDES, ANTISENSE; PROTEIN KINASE C-ALPHA; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SKIN; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 37349074107     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21207     Document Type: Article

References (30)

1. Brooks G, Goss MW, East JA, Hart IR. 1993. Growth of melanocytic cells is associated with down-regulation of protein kinase C alpha, delta, and epsilon isoforms. Possible role of diacylglycerol. J Biol Chem 268:23868-23875.
2. Buitrago CG, Pardo VG, de Boland AR, Boland R. 2003. Activation of RAF-1 through Ras and protein kinase Calpha mediates 1alpha,25(OH)2-vitamin D3 regulation of the mitogen-activated protein kinase pathway in muscle cells. J Biol Chem 278:2199-2205.
3. Chen T, Triplett J, Dehner B, Hurst B, Colligan B, Pemberton J, Graff JR, Carter JH. 2001. Transforming growth factor-beta receptor type 1 gene is frequently mutated in ovarian carcinomas. Cancer Res 61:4679-4682.
4. Chuang CC, Tan SK, Tai LK, Hsin JP, Wang FF. 1998. Evidence for the involvement of protein kinase C in the inhibition of prolactin gene expression by transforming growth factor-β2. Mol Pharmacol 53:1054-1061.
5. Dean NM, McKay R, Condon TP, Bennett CF. 1994. Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. J Biol Chem 269:16416-16424.
6. Eisinger M, Marko O, Weinstein IB. 1983. Stimulation of growth of human melanocytes by tumor promoters. Carcinogenesis 4:779-781.
7. Goerttler K, Hecker E, Loehrke H, Seip H, Hesse B, Schweitzer J. 1982. Effect of the tumor promoter 12-O-tetradecanoylphorbol-13-acetate and its nonpromoting analogue 4-O-methyl-TPA on dorsal dermal melanocytes of the Syrian golden hamster (Mesocricetus auratus). J Cancer Res Clin Oncol 103:305-311.
8. Hempel A, Maasch C, Heintze U, Lindschau C, Dietz R, Luft FC, Haller H. 1997. High glucose concentrations increase endothelial cell permeability via activation of protein kinase C α. Circ Res 81:363-371.
9. Kanno J, Matsubara O, Kasuga T. 1986. Histogenesis ofthe intradermal melanocytic tumor in BDFI mice induced by topical application of 9,10-dimethyl-1,2-benzanthracene (DMBA) and 12-O-tetradecanoylphorbol- acetate (TPA). Acta Pathol Jpn 36:1-14.
10. Kardassis D, Pardali K, Zannis VI. 2000. SMAD proteins transactivate the human ApoCIII promoter by interacting physically and functionally with hepatocyte nuclear factor 4. J Biol Chem 275:41405-41414.
11. Krasagakis K, Garbe C, Krüger-Krasagakes S, Orfanos CE. 1993. 12-O-Tetradecanoyl-phorbol-13-acetate not only modulates proliferation rates, but also alters antigen expression and LAK-cell susceptibility of normal human melanocytes in vitro. J Invest Dermatol 100:653-659.
12. Krasagakis K, Garbe C, Schrier PI, Orfanos CE. 1994. Paracrine and autocrine regulation of human melanocyte and melanoma cell growth by transforming growth factor beta in vitro. Anticancer Res 14:2565-2572.
13. Krasagakis K, Krüger-Krasagakes S, Fimmel S, Thölke D, Eberle J, von der Ohe M, Mansmann U, Orfanos CE. 1999. Desensitization of melanoma cells to autocrine TGF-β isoforms. J Cell Physiol 178:179-187.
14. Krasagakis K, Fimmel S, Genten D, Eberle J, Quas P, Ziegler W, Haller H, Orfanos CE. 2002. Lack of protein kinase C (PKC)-α and low PKC-δ, -ε and -ζ isozyme levels in proliferating melanoma cells. Int J Oncol 20:865-871.
15. Krasagakis K, Lindschau C, Quass P, Fimmel S, Eberle J, Haller H, Orfanos CE. 2004. Proliferation of human melanoma cells is under tight control of protein kinase C alpha. J Cell Physiol 199:381-387.
16. Medrano EE. 2003. Repression of TGF-beta signaling by the oncogenic protein SKI in human melanomas: Consequences for proliferation, survival, and metastasis. Oncogene 22:3123-3129.
17. Miyaki M, Kuroki T. 2003. Role of Smad4 (DPC4) inactivation in human cancer. Biochem Biophys Res Commun 306:799-804.
18. Moustakas A, Heldin CH. 2005. Non-Smad TGF-β signals. J Cell Sci 118:3573-3584.
19. Nerlich AG, Sauer U, Ruoss I, Hagedorn HG. 2003. High frequency of TGF-beta-receptor-II mutations in microdissected tissue samples from laryngeal squamous cell carcinomas. Lab Invest 83:1241-1251.
20. Park K, Kim SJ, Bang YJ, Park JG, Kim NK, Roberts AB, Sporn MB. 1994. Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: Correlation with sensitivity to growth inhibition by TGF-beta. Proc Natl Acad Sci USA 91:8772-8776.
21. Reed JA, Bales E, Xu W, Okan NA, Bandyopadhyay D, Medrano EE. 2001. Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: Functional implications for transforming growth factor beta signaling. Cancer Res 61:8074-8078.
22. Rodeck U, Bossler A, Graeven U, Fox FE, Nowell PC, Knabbe C, Kari C. 1994. Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells. Cancer Res 54:575-581.
23. Rodeck U, Nishiyama T, Mauviel A. 1999. Independent regulation of growth and SMAD-mediated transcription by transforming growth factor beta in human melanoma cells. Cancer Res 59:547-550.
24. Sakaguchi M, Miyazaki M, Sonegawa H, Kashiwagi M, Ohba M, Kuroki T, Namba M, Huh N-H. 2004. PKCα mediates TGFβ-induced growth inhibition of human keratinocytes via phosphorylation of S100C/A11. J Cell Biol 164:979-984.
25. ten Dijke P, Hill CS. 2004. New insights into TGF-β-Smad signaling. Trends Biochem Sci 29:265-273.
26. Weiss RH, Ramirez A. 1998. TGF-beta- and angiotensin-II-induced mesangial matrix protein secretion is mediated by protein kinase C. Nephrol Dial Transplant 13:2804-2813.
27. Wilkinson SE, Parker PJ, Nixon JS. 1993. Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem J 294:335-337.
28. Yakymovych I, ten Dijke P, Heldin CH, Souchelnychkyi S. 2001. Regulation of Smad signaling by protein kinase C. FASEB J 15:553-555.
29. 2 release. Am J Hypertens 10:32-42.
30. Zouboulis CC, Garbe C, Krasagakis K, Krüger S, Orfanos CE. 1991. A fluorometric rapid microassay to identify antiproliferative compounds for human melanoma cells in vitro. Melanoma Res 1:91-96.